跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,527 条关于
“Naxitamab 15-096”
全部
8,527
临床试验
2,378
药物
1,305
机构
123
资讯
4,721
去年
Osteosarcoma Market Poised for Significant Growth Through 2034 as Novel Therapies Enter Pipeline
去年
Naxitamab Shows Promising Results in Phase 2 Trial for High-Risk Neuroblastoma
去年
Naxitamab Shows Promising Results in Treating Relapsed/Refractory High-Risk Neuroblastoma
8个月前
Herantis Pharma's HER-096 Shows Biological Activity in Parkinson's Disease Phase 1b Trial
8个月前
Herantis Pharma's HER-096 Shows Biological Activity in Parkinson's Disease Phase 1b Trial
去年
Herantis Pharma Advances HER-096 in Phase 1b Trial for Parkinson's Disease with Promising Pharmacokinetic Data
去年
Herantis Pharma Advances HER-096 for Parkinson's Disease: Final Cohort of Phase 1b Trial Now Underway
去年
Herantis Pharma Completes Phase 1b Trial of HER-096 for Parkinson's Disease, Topline Results Expected Within Nine Weeks
去年
New Clinical Trial Tests Tipifarnib and Naxitamab Combination for Neuroblastoma
2年前
IBI363 Receives FDA Designation, Advancing Treatment for Unspecified Condition
第 1 页,共 473 页
上一页
下一页